Benzinga · Oct 9, 2026
UBS Initiates Coverage On AptarGroup with Neutral Rating, Announces Price Target of $135
UBS analyst Anojja Shah initiates coverage on AptarGroup (NYSE:ATR) with a Neutral rating and announces Price Target of $135.

NYSE · ATR
Healthcare · Medical - Instruments & Supplies
$119.21
Up+$1.06 (+0.89%)
Updated Oct 15, 2026, 12:00 AM
SID Score
4.4/10
Composite research score
Smart Money
58/100
Neutral
Price performance · ATR
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
ATR closed at $119.21 after 20 trading sessions, down 4.41% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $120.21 | $120.625 | $118.34 | $119.21 | 795.7K |
| Oct 12, 2026 | $120.21 | $121.03 | $118.87 | $118.95 | 476.76K |
| Oct 9, 2026 | $121.47 | $121.52 | $119.5001 | $120.38 | 542.18K |
| Oct 8, 2026 | $119.93 | $122.42 | $119.91 | $121.81 | 602.4K |
| Oct 7, 2026 | $121.17 | $121.325 | $119.8592 | $120.43 | 605.91K |
| Oct 6, 2026 | $119.97 | $121.13 | $118.86 | $120.25 | 721.52K |
| Oct 5, 2026 | $119.28 | $121.37 | $118.78 | $120.61 | 413.13K |
| Oct 2, 2026 | $121.34 | $121.97 | $119.735 | $119.91 | 383.98K |
| Oct 1, 2026 | $120.22 | $121.62 | $119.215 | $120.87 | 389.01K |
| Sep 30, 2026 | $123.07 | $123.07 | $121.13 | $121.16 | 424.12K |
| Sep 29, 2026 | $123.83 | $124.665 | $122.12 | $123.29 | 409.84K |
| Sep 28, 2026 | $122.89 | $124.59 | $122.09 | $124.45 | 713.33K |
| Sep 25, 2026 | $123.76 | $124.05 | $122.42 | $123.87 | 325.65K |
| Sep 24, 2026 | $124.51 | $124.99 | $122.32 | $123.38 | 377.18K |
| Sep 23, 2026 | $125.43 | $125.72 | $124.50 | $124.74 | 335.32K |
| Sep 22, 2026 | $124.72 | $125.7999 | $123.825 | $125.45 | 417.72K |
| Sep 21, 2026 | $124.84 | $125.98 | $123.32 | $123.40 | 424.45K |
| Sep 18, 2026 | $125.49 | $125.77 | $124.41 | $124.44 | 821.26K |
| Sep 17, 2026 | $125.66 | $126.22 | $124.55 | $125.50 | 551.46K |
| Sep 16, 2026 | $124.84 | $126.25 | $123.2001 | $124.71 | 461.61K |
The latest Smart Investors Daily articles mentioning ATR.
Company
Market Activity
Research & News
ATR research
Company profile and research snapshot.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 9, 2026 | UBS | Neutral | — |
| Aug 3, 2026 | Wells Fargo | Overweight | — |
| May 4, 2026 | Wells Fargo | Overweight | — |
| Mar 20, 2026 | Wells Fargo | Overweight | — |
| Jan 6, 2026 | Wells Fargo | Equal-Weight | — |
No generated briefing is available yet.
Benzinga · Oct 9, 2026
UBS analyst Anojja Shah initiates coverage on AptarGroup (NYSE:ATR) with a Neutral rating and announces Price Target of $135.
Yahoo · Oct 5, 2026
AptarGroup (ATR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Yahoo · Sep 28, 2026
AVY, ATR and KRT are navigating weak packaging demand with pricing, cost controls and growth in e-commerce and eco-friendly products.
SeekingAlpha · Sep 27, 2026
AptarGroup stays on hold: revenue rises but profitability lags and valuation looks rich vs. peers. Click for more on ATR stock.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ATR.